T1	Treatment 455 595	virulent NIA-3 strain or the avirulent Bartha strain, or they were inoculated IM with an inactivated vaccine containing the Phylaxia strain.
T2	Treatment 627 676	challenge-exposed intranasally with strain NIA-3.
